AAAAAA

   
Results: 1-11 |
Results: 11
Specific immunotherapy by genetically engineered APCs: The "guided missile" strategy
Authors: Wu, B Wu, JM Miagkov, A Adams, RN Levitsky, HI Drachman, DB
Citation: B. Wu et al., Specific immunotherapy by genetically engineered APCs: The "guided missile" strategy, J IMMUNOL, 166(7), 2001, pp. 4773-4779
Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression
Authors: Sotomayor, EM Borrello, I Rattis, FM Cuenca, AG Abrams, J Staveley-O'Carroll, K Levitsky, HI
Citation: Em. Sotomayor et al., Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression, BLOOD, 98(4), 2001, pp. 1070-1077
When magic bullets miss their mark
Authors: Levitsky, HI
Citation: Hi. Levitsky, When magic bullets miss their mark, BLOOD, 97(4), 2001, pp. 833-833
Augmentation of host immune responses to cancer: Overcoming the barrier oftumor antigen-specific T-cell tolerance
Authors: Levitsky, HI
Citation: Hi. Levitsky, Augmentation of host immune responses to cancer: Overcoming the barrier oftumor antigen-specific T-cell tolerance, CANCER J, 6, 2000, pp. S281-S290
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies
Authors: Nelson, WG Simons, JW Mikhak, B Chang, JF DeMarzo, AM Carducci, MA Kim, M Weber, CE Baccala, AA Goeman, MA Clift, SM Ando, DG Levitsky, HI Cohen, LK Sanda, MG Mulligan, RC Partin, AW Carter, HB Piantadosi, S Marshall, FF
Citation: Wg. Nelson et al., Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies, CANC CHEMOT, 46, 2000, pp. S67-S72
CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic Tlymphocytes
Authors: Lu, ZB Yuan, LX Zhou, XZ Sotomayor, E Levitsky, HI Pardoll, DM
Citation: Zb. Lu et al., CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic Tlymphocytes, J EXP MED, 191(3), 2000, pp. 541-550
Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSE)-producingtumor vaccines
Authors: Borrello, I Sotomayor, EM Ratiis, FM Cooke, SK Gu, LP Levitsky, HI
Citation: I. Borrello et al., Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSE)-producingtumor vaccines, BLOOD, 95(10), 2000, pp. 3011-3019
Conversion of tumor-specific CD4(+) T-cell tolerance to T-cell priming through in vivo ligation of CD40
Authors: Sotomayor, EM Borrello, I Tubb, E Rattis, FM Bien, H Lu, ZB Fein, S Schoenberger, S Levitsky, HI
Citation: Em. Sotomayor et al., Conversion of tumor-specific CD4(+) T-cell tolerance to T-cell priming through in vivo ligation of CD40, NAT MED, 5(7), 1999, pp. 780-787
A universal granulocyte-macrophage colony-stimulating factor-producing bystander cell line for use in the formulation of autologous tumor cell-based vaccines
Authors: Borrello, I Sotomayor, EM Cooke, S Levitsky, HI
Citation: I. Borrello et al., A universal granulocyte-macrophage colony-stimulating factor-producing bystander cell line for use in the formulation of autologous tumor cell-based vaccines, HUM GENE TH, 10(12), 1999, pp. 1983-1991
In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance
Authors: Sotomayor, EM Borrello, I Tubb, E Allison, JP Levitsky, HI
Citation: Em. Sotomayor et al., In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance, P NAS US, 96(20), 1999, pp. 11476-11481
Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer
Authors: Simons, JW Mikhak, B Chang, JF DeMarzo, AM Carducci, MA Lim, M Weber, CE Baccala, AA Goemann, MA Clift, SM Ando, DG Levitsky, HI Cohen, LK Sanda, MG Mulligan, RC Partin, AW Carter, HB Piantadosi, S Marshall, FF Nelson, WG
Citation: Jw. Simons et al., Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer, CANCER RES, 59(20), 1999, pp. 5160-5168
Risultati: 1-11 |